BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3830952)

  • 1. The correlation between estrogen and progesterone receptors and some clinical and pathological features in human breast cancer.
    Caldarola L; Volterrani P; Lai M; Vigezzi P; Gaglia P
    Ital J Surg Sci; 1985; 15(4):329-33. PubMed ID: 3830952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
    Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
    Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A; Pascual MR; Pérez R; Lage A
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.
    Bernoux A; de Cremoux P; Lainé-Bidron C; Martin EC; Asselain B; Magdelénat H
    Breast Cancer Res Treat; 1998 Jun; 49(3):219-25. PubMed ID: 9776505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid receptors and prognosis in operable (stage I and II) breast cancer.
    Stewart JF; Rubens RD; Millis RR; King RJ; Hayward JL
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1381-7. PubMed ID: 6315442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone receptors as prognostic factors in breast cancer.
    Brdar B; Graf D; Padovan R; Nola P; Rudan N; Petrinec Z; Sarcević B; Belicza M
    Tumori; 1988 Feb; 74(1):45-52. PubMed ID: 3354064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology.
    Thorpe SM; Rose C
    Cancer Surv; 1986; 5(3):505-25. PubMed ID: 3555780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of steroid receptors with histopathologic characteristics in breast carcinoma.
    Bhatavdekar JM; Trivedi SN; Shah NG; Karelia NH; Patel DD; Giri DD; Patel TB
    Neoplasma; 1988; 35(4):413-23. PubMed ID: 3185838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients.
    Vollenweider-Zerargui L; Barrelet L; Wong Y; Lemarchand-Béraud T; Gómez F
    Cancer; 1986 Mar; 57(6):1171-80. PubMed ID: 3943040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer.
    Nishimura R; Misumi A; Kimura M; Tokunaga T; Akagi M
    Jpn J Surg; 1982; 12(3):191-7. PubMed ID: 6290728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].
    Chevallier B; Heintzman F; Asselain B; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M
    Bull Cancer; 1988; 75(1):23-36. PubMed ID: 3359056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between steroid hormone receptors and prognostic factors in human breast cancer.
    Barbi GP; Marroni P; Bruzzi P; Nicolò G; Paganuzzi M; Ferrara GB
    Oncology; 1987; 44(5):265-9. PubMed ID: 3670793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human breast cancer: survival from first metastasis. Breast Cancer Study Group.
    Koenders PG; Beex LV; Kloppenborg PW; Smals AG; Benraad TJ
    Breast Cancer Res Treat; 1992; 21(3):173-80. PubMed ID: 1515652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
    Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
    Redkar AA; Kabre SS; Mittra I
    Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.